Atria Wealth Solutions’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-359,575
Closed -$575K 2021
2023
Q1
$575K Buy
359,575
+32,266
+10% +$65.6K 0.01% 1050
2022
Q4
$651K Buy
327,309
+142,561
+77% +$351K 0.01% 956
2022
Q3
$643K Buy
184,748
+55,021
+42% +$210K 0.01% 898
2022
Q2
$442K Buy
129,727
+91,399
+238% +$504K 0.01% 1034
2022
Q1
$350K Buy
+38,328
New +$582K 0.01% 1247

Other funds holding SRGA

Atria Wealth Solutions's SRGA Position: Q2 2023 in Review

Atria Wealth Solutions sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q2 2023, closing a stake of 359,575 shares — an estimated $575K sold.

Atria Wealth Solutions first reported a position in SRGA in Q1 2022 and held it in 5 quarters. The position peaked at $651K in Q4 2022. 25 funds tracked by Wall St. Rank hold SRGA as of Q2 2023.

  • Atria Wealth Solutions reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Atria Wealth Solutions sold 359,575 Surgalign Holdings, Inc. Common Stock shares in Q2 2023, an estimated $575K.
  • Atria Wealth Solutions first reported a position in Surgalign Holdings, Inc. Common Stock in Q1 2022 and held it in 5 quarters.
  • Atria Wealth Solutions's Surgalign Holdings, Inc. Common Stock position peaked at $651K in Q4 2022.
  • 25 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q2 2023.

Based on Atria Wealth Solutions's 13F filing for Q2 2023, filed 3 Aug 2023.